ProKidney
PROK
56 hedge funds and large institutions have $446M invested in ProKidney in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 20 increasing their positions, 3 reducing their positions, and 6 closing their positions.
1,225% more call options, than puts
Call options by funds: $106K | Put options by funds: $8K
567% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 3
350% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 6
60% more funds holding
Funds holding: 35 → 56 (+21)
14% more capital invested
Capital invested by funds: $391M → $446M (+$54.4M)
8.48% more ownership
Funds ownership: 56.17% → 64.65% (+8.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$32M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.9M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.63M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4.5M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$2.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.6M |
| 2 |
Millennium Management
New York
|
-$1.16M |
| 3 |
HF
HRT Financial
New York
|
-$730K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$564K |
| 5 |
Squarepoint
New York
|
-$293K |
PROK Hedge Fund Activity: Q2 2023 in Review
56 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2023, worth a combined $446M — up 14% from $391M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new PROK positions and 6 closed out — a net gain of 21 holders — while 20 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $32M. The largest seller was Vanguard Group, cutting an estimated $11.6M.
- 56 institutional investors held ProKidney (PROK) as of Q2 2023, up from 35 in Q1 2023.
- Funds reported $446M of ProKidney stock for Q2 2023, up 14% quarter-over-quarter.
- 27 funds opened new ProKidney positions in Q2 2023 and 6 closed out, a net change of +21 holders.
- The largest ProKidney buyer in Q2 2023 was BlackRock, an estimated $32M added.
- The largest ProKidney seller in Q2 2023 was Vanguard Group, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2023.